NEW YORK (GenomeWeb News) – Plant genomics company Evogene today announced an extension of its deal with Syngenta aimed at developing soybeans resistant to a plant parasite nematode.

The deal extends an agreement originally forged in 2009 by the two firms to identify genes that provide resistance to soybean cyst nematode, a pest that is responsible for about $100 billion in crop damages annually. In the US, nematode-related losses to soybean growers are estimated to reach $1.3 billion annually, Evogene said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.